Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
NCT ID: NCT07334314
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
340 participants
OBSERVATIONAL
2025-06-20
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Detect the Sensitivity of the UroMark Assay
NCT02781428
Urine-based Detection of Non-muscle Invasive Bladder
NCT03962933
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
NCT07095751
Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma
NCT02326909
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Positive bladder tumor
Bladder tumor present during cystoscopy and confirmed by pathological examination.
olfactory detection by dogs
olfactory detection of urothelial carcinoma of the bladder in a urine sample by dogs
Negative bladder tumor
No bladder tumor on cystoscopy/suspicious lesion but with negative pathological analysis
olfactory detection by dogs
olfactory detection of urothelial carcinoma of the bladder in a urine sample by dogs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
olfactory detection by dogs
olfactory detection of urothelial carcinoma of the bladder in a urine sample by dogs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject scheduled for any endourological surgery involving an initial cystoscopy, the most common of which are: transurethral resection of the bladder, transurethral resection of the prostate, internal optical urethrotomy, bladder lithoclast, ureteral stent replacement, ureteroscopy, etc. (non-exhaustive list)
* Subjects for whom a urine sample (for bacteriological or cytological testing) is planned as part of routine practice in the month prior to the procedure
* Subjects affiliated with a health insurance plan or beneficiaries of such a plan
Exclusion Criteria
* Patient under guardianship, conservatorship, or judicial protection
* History of cancer other than urothelial bladder carcinoma, unless in complete remission for \> 5 years
* Pregnant or breastfeeding women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpitaux Civils de Colmar
Colmar, , France
Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9630
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.